Stock Trading Canary

Built: 2026-10-19T16:02:49+00:00 · 中文

← South Korea

SOUTH KOREA · OPENDART

L&C BIO Co., Ltd

엘앤씨바이오 · 290650 · KOSDAQ · Healthcare · Medical Devices

Score

Not ranked: no net buying on the exchange by an individual insider in the last 180 days.

Insiders' buying price vs the latest close

Insiders paid 56,333.01 KRW a share on average (5 purchase lines, 1 buyer, 2025-11-13 – 2026-01-12). The close on 2026-10-16 was 24.4% above that price.

The latest purchase (2026-01-12) was at 57,500.00 KRW; the close was 21.9% above that price.

Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.

Insider trades on the exchange

Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.

Trade dateInsiderRoleTradeSharesPriceValueFiling
2026-02-19Han Bang-HeeVice presidentSold on the exchange10,000₩104,847₩1.0BDART ↗
2026-02-13Lee Hyun SeungDirectorSold on the exchange350₩98,500₩34.5MDART ↗
2026-01-28Han Bang-HeeVice presidentSold on the exchange20,000₩74,765₩1.5BDART ↗
2026-01-27Lee whan-chulCEOSold on the exchange100₩77,700₩7.8MDART ↗
2026-01-12Son sukwooManaging directorBought on the exchange869₩57,500₩50.0MDART ↗
2025-12-30Son sukwooManaging directorBought on the exchange327₩61,100₩20.0MDART ↗
2025-12-29Son sukwooManaging directorBought on the exchange484₩61,900₩30.0MDART ↗
2025-12-22LIM SOOSUNGManaging directorSold on the exchange16,050₩67,001₩1.1BDART ↗
2025-12-19LIM SOOSUNGManaging directorSold on the exchange13,950₩70,081₩977.6MDART ↗
2025-11-13Son sukwooManaging directorBought on the exchange395₩50,600₩20.0MDART ↗
2025-11-13Son sukwooManaging directorBought on the exchange585₩51,200₩30.0MDART ↗
Other changes in holdings · 25

Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.

DateInsiderRoleReasonSharesFiling
2026-09-22Lee whan-chulCEODisposal in OTC(-)428,909DART ↗
2026-09-16Han Bang-HeeVice presidentOthers(+)3,053DART ↗
2026-09-16Lee Kwang-InManaging directorOthers(+)4,590DART ↗
2026-09-16Shin SungHoonManaging directorOthers(+)2,142DART ↗
2026-09-16Son sukwooManaging directorOthers(+)496DART ↗
2026-09-16Kim Ki-MinManaging directorOthers(+)5,424DART ↗
2026-09-16Lee whan-chulCEOOthers(+)857,817DART ↗
2026-09-11Lee whan-chulCEOOff-hour trading(-)826,276DART ↗
2026-08-12Nau IB 19th Fund10% shareholderDisposal in exchange(-)58,103DART ↗
2026-08-11Nau IB 19th Fund10% shareholderDisposal in exchange(-)34,421DART ↗
2026-08-10Nau IB 19th Fund10% shareholderDisposal in exchange(-)158,325DART ↗
2026-08-07Nau IB 19th Fund10% shareholderDisposal in exchange(-)37,566DART ↗
2026-08-06Nau IB 19th Fund10% shareholderDisposal in exchange(-)102,900DART ↗
2026-08-05Nau IB 19th Fund10% shareholderDisposal in exchange(-)9,465DART ↗
2026-04-23Nau IB 19th Fund10% shareholderNew registration(+)493,828DART ↗
2026-04-23Nau IB 19th Fund10% shareholderExercise of convertible bond rights(+)2,122,641DART ↗
2026-04-23Nau IB 19th Fund10% shareholderNew registration(+)707,547DART ↗
2026-02-11Shin SungHoonManaging directorStock options(+)5,000DART ↗
2026-02-02Lee Hyun SeungDirectorNew appointment(+)350DART ↗
2025-12-18Han Bang-HeeVice presidentExercise of appraisal rights(+)40,000DART ↗
2025-12-18LIM SOOSUNGManaging directorExercise of appraisal rights(+)30,000DART ↗
2025-06-29Lee whan-chulCEOExtinguishment of conversion rights, etc.(-)314,253DART ↗
2025-05-26Lee whan-chulCEOOthers(+)187,000DART ↗
2025-05-26Lee whan-chulCEOOthers(-)187,000DART ↗
2020-12-03Shin SungHoonManaging directorNew appointment(+)10,800DART ↗